These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 4968414)

  • 21. [Changes in the bacteriologic findings in patients treated with rifomycin, alone or associated with other drugs].
    Delli Veneri F; Centrella G; Stefanelli R
    Arch Tisiol Mal Appar Respir; 1968 May; 23(5):387-98. PubMed ID: 4979475
    [No Abstract]   [Full Text] [Related]  

  • 22. [Drug dependance of Mycobacterium tuberculosis].
    Mel'nikov EL
    Probl Tuberk; 1969; 47(5):60-4. PubMed ID: 4983819
    [No Abstract]   [Full Text] [Related]  

  • 23. [Heterogeneity of drug-resistant strains of Mycobacterium tuberculosis].
    Belogurova VP
    Probl Tuberk; 1970; 48(9):76-9. PubMed ID: 4996497
    [No Abstract]   [Full Text] [Related]  

  • 24. [Comparative characteristics of disseminated pulmonary tuberculosis in patients isolating Mycobacterium tuberculosis with a high and low viability].
    Koretskaia NM; Iarygina IV
    Probl Tuberk Bolezn Legk; 2007; (2):17-20. PubMed ID: 17419328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Selection of optimal antibacterial drugs for test therapy in differential diagnosis of pulmonary tuberculosis and pneumonia].
    Rudoĭ NM; Khauadamova GT
    Ter Arkh; 1980; 52(3):62-4. PubMed ID: 6770483
    [No Abstract]   [Full Text] [Related]  

  • 26. [Results of antibacterial treatment of patients with bacteriologically confirmed pulmonary tuberculosis in Poland 1982].
    Szczuka I
    Pneumonol Pol; 1984 Sep; 52(9):409-18. PubMed ID: 6442409
    [No Abstract]   [Full Text] [Related]  

  • 27. [Durable character of the sterilization of experimental tuberculosis in mice by rifampicin-isoniazid association: cortisone test].
    Grumbach F; Canetti G; Le Lirzin M
    Rev Tuberc Pneumol (Paris); 1970 Mar; 34(2):312-9. PubMed ID: 4994882
    [No Abstract]   [Full Text] [Related]  

  • 28. [Etiopathogenetic therapy in adolescent patients with drug-resistant Mycobacterium tuberculosis in respiratory tuberculosis].
    Pavlova MV; Skvortsova LA; Kondakova MN; Sapozhnikova NV
    Probl Tuberk Bolezn Legk; 2004; (1):24-6. PubMed ID: 15137140
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Streptomycin-dependent Mycobacterium tuberculosis].
    Egorova NG; Ravich IB
    Probl Tuberk; 1972; 50(1):85-6. PubMed ID: 4622060
    [No Abstract]   [Full Text] [Related]  

  • 30. Activity of diclofenac used alone and in combination with streptomycin against Mycobacterium tuberculosis in mice.
    Dutta NK; Mazumdar K; Dastidar SG; Park JH
    Int J Antimicrob Agents; 2007 Oct; 30(4):336-40. PubMed ID: 17644321
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Rifamicin in the studies of the Scuola Tisiologica in Naples].
    Nitti V
    Arch Tisiol Mal Appar Respir; 1968 Apr; 23(4):271-92. PubMed ID: 4981409
    [No Abstract]   [Full Text] [Related]  

  • 32. Anti-TB drug resistance levels and patterns among Mycobacterium tuberculosis isolated from newly diagnosed cases of pulmonary tuberculosis in Dar es Salaam, Tanzania.
    Matee M; Mfinanga S; Holm-Hansen C
    APMIS; 2009 Apr; 117(4):263-7. PubMed ID: 19338514
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bacteriologic basis of short-course chemotherapy for tuberculosis.
    Grosset J
    Clin Chest Med; 1980 May; 1(2):231-41. PubMed ID: 6794976
    [No Abstract]   [Full Text] [Related]  

  • 34. [Resensitization of resistant mycobacterial strains to antitubercular drugs].
    Vercellino E
    G Mal Infett Parassit; 1968 Feb; 20(2):191-3. PubMed ID: 4984621
    [No Abstract]   [Full Text] [Related]  

  • 35. [Bacteriologic negation and anatomic development in pulmonary specimens after rifampicin treatment of less than 10 months (10 cases)].
    Constans P; Parrot R; Coury C
    Rev Tuberc Pneumol (Paris); 1970 Jun; 34(4):511-8. PubMed ID: 4994883
    [No Abstract]   [Full Text] [Related]  

  • 36. Primary resistance to the major drugs in tuberculous patients, in 1961-1966.
    Jaroszewicz W; Buraczewska M; Pichulowa K; Pszonicka A; Zych D
    Pol Med J; 1969; 8(5):1131-5. PubMed ID: 4986628
    [No Abstract]   [Full Text] [Related]  

  • 37. Course of cases of pulmonary tubercurosis with bacilli resistant to streptmycin, para-aminosalicylic acid and isoniazid and with multiple drug-resistance.
    Oka S
    Sci Rep Res Inst Tohoku Univ Med; 1969 Dec; 16(3):106-9. PubMed ID: 4988512
    [No Abstract]   [Full Text] [Related]  

  • 38. [On the lability of the degree of drug resistance of Mycobacterium tuberculosis strains].
    Belogurova VP
    Antibiotiki; 1967 Aug; 12(8):718-22. PubMed ID: 4968418
    [No Abstract]   [Full Text] [Related]  

  • 39. [Occurrence and clinical importance of drug resistance of Mycobacterium tuberculosis in patients with pulmonary tuberculosis].
    Kuznetsova EE
    Probl Tuberk; 1970; 48(9):39-43. PubMed ID: 4996495
    [No Abstract]   [Full Text] [Related]  

  • 40. [Resistance of Mycobacterium tuberculosis in Ferrol, Spain. Associated factors].
    García Rodríguez JF; Mariño Callejo A; Lorenzo García MV; Rodríguez Mayo M; Domínguez Gómez D; Sesma Sánchez P
    Med Clin (Barc); 1999 Nov; 113(15):572-4. PubMed ID: 10605682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.